1 5866 112 SUPPRESSION OF MICRORNA-9-5P RESCUES LEARNING AND MEMORY IN CHRONIC CEREBRAL HYPOPERFUSION RATS MODEL. CHRONIC CEREBRAL HYPOPERFUSION HAS BEEN ASSOCIATED WITH COGNITIVE IMPAIRMENT IN DEMENTIAS, SUCH AS ALZHEIMER'S DISEASE (AD) AND VASCULAR DISEASE (VAD), THE TWO MOST COMMON NEURODEGENERATIVE DISEASES IN AGED PEOPLE. HOWEVER, THE EFFECTIVE THERAPEUTIC APPROACHES FOR BOTH AD AND VAD ARE STILL MISSING. MICRORNAS (MIRNAS) ARE SMALL NON-CODING RNAS THAT PLAY IMPORTANT ROLES IN THE EPIGENETIC REGULATION IN MANY NEUROLOGICAL DISORDERS; THE CRITICAL ROLES OF MIRNADEREGULATION HAD BEEN IMPLICATED IN BOTH AD AND VAD. IN THE CURRENT STUDY, WE REPORTED THAT MIR-9-5P IS ELEVATED IN THE SERUM AND CEREBROSPINALFLUID OF PATIENTSWITH VAD. THE MIR-9-5P WASALSO INCREASED IN BOTH THE HIPPOCAMPUS AND CORTEX OF RATS WITH 2-VESSEL OCCLUSIONSURGERY. FURTHERMORE, APPLICATION OFMIR-9-5P ANTAGOMIRS ATTENUATED THE MEMORY IMPAIRMENTS IN RATS WITH 2-VESSEL OCCLUSION SURGERY BOTH IN THE MORRIS WATER MAZE AND INHIBITORY AVOIDANCE STEP-DOWN TASKS. FURTHERMORE, MIR-9-5P ANTAGOMIRS REDUCEDTHE INHIBITION OFLONG-TERM POTENTIATION AND LOSS OF DENDRITIC SPINES IN CHRONIC CEREBRAL HYPOPERFUSIONRATS. ADDITIONALLY, THE CHOLINERGIC NEURONAL FUNCTION WAS RESCUED BY MIR-9-5P ANTAGOMIRS, AS WELL AS THE NEURONAL LOSS AND THE OXIDATIVE STRESS. WE CONCLUDED THAT MIR-9-5P INHIBITION MAY BE A POTENTIAL THERAPEUTIC TARGET FOR THE MEMORY IMPAIRMENTS CAUSED BY CHRONIC CEREBRAL HYPOPERFUSION. 2017 2 2886 28 GABA-AALPHA5 MIGHT BE INVOLVED IN LEARNING-MEMORY DYSFUNCTION IN THE OFFSPRINGS OF CHRONIC ETHANOL-TREATED RATS VIA GABA-AALPHA5 HISTONE H3K9 ACETYLATION. RECENTLY, NUMEROUS STUDIES HAVE BEEN FOCUSED ON THE RELATIONSHIP BETWEEN GABA-A RECEPTORS AND ALCOHOL-INDUCED SPATIAL LEARNING AND MEMORY DEFICITS. GABA-AALPHA5, A SUBUNIT OF GABA-A RECEPTORS, IS CONSIDERED TO PLAY AN IMPORTANT ROLE IN ALCOHOL-INDUCED COGNITIVE IMPAIRMENT, HOWEVER, THE MECHANISM REMAINS OBSCURE. IN THIS STUDY, WE FOUND THAT THE EXPRESSION OF GABA-AALPHA5 INCREASED IN RATS TREATED WITH CHRONIC ETHANOL VIA HISTONE H3K9 ACETYLATION. FURTHERMORE, THIS EPIGENETIC MODIFICATION COULD BE INHERITED BY THE NEXT GENERATIONS, WHICH EVENTUALLY EXHIBIT SIMILAR SPATIAL LEARNING AND MEMORY DEFICITS IN THE OFFSPRINGS. IN SUMMARY, OUR RESULTS SUGGESTED THAT GABA-AALPHA5 MIGHT BE INVOLVED IN CHRONIC ETHANOL TREATMENT-INDUCED LEARNING-MEMORY DYSFUNCTION AND FOR THE FIRST TIME PROVED THAT LEARNING-MEMORY DYSFUNCTION COULD BE INHERITED BY THE OFFSPRINGS VIA HISTONE H3K9 ACETYLATION. HOPEFULLY, IN THE NEAR FUTURE, GABA-AALPHA5 INHIBITORS WOULD BE AN EFFECTIVE WAY TO TREAT ALCOHOL-INDUCED COGNITION IMPAIRMENT. 2019 3 889 31 CHRONIC DIETARY ADMINISTRATION OF VALPROIC ACID PROTECTS NEURONS OF THE RAT NUCLEUS BASALIS MAGNOCELLULARIS FROM IBOTENIC ACID NEUROTOXICITY. VALPROIC ACID (VPA) HAS BEEN USED FOR MANY YEARS AS A DRUG OF CHOICE FOR EPILEPSY AND MOOD DISORDERS. RECENTLY, EVIDENCE HAS BEEN PROPOSED FOR A WIDE SPECTRUM OF ACTIONS OF THIS DRUG, INCLUDING ANTITUMORAL AND NEUROPROTECTIVE PROPERTIES. VALPROIC ACID-MEDIATED NEUROPROTECTION IN VIVO HAS BEEN SO FAR DEMONSTRATED IN A LIMITED NUMBER OF EXPERIMENTAL MODELS. IN THIS STUDY, WE HAVE TESTED THE NEUROPROTECTIVE POTENTIAL OF CHRONIC (4 + 1 WEEKS) DIETARY ADMINISTRATION OF VPA ON DEGENERATION OF CHOLINERGIC AND GABAERGIC NEURONS OF THE RAT NUCLEUS BASALIS MAGNOCELLULARIS (NBM), INJECTED WITH THE EXCITOTOXIN, IBOTENIC ACID (IBO), AN ANIMAL MODELS THAT IS RELEVANT FOR ALZHEIMER'S DISEASE-LIKE NEURODEGENERATION. WE SHOW THAT VPA TREATMENT SIGNIFICANTLY PROTECTS BOTH CHOLINERGIC AND GABAERGIC NEURONS PRESENT IN THE INJECTED AREA FROM THE EXCITOTOXIC INSULT. A SIGNIFICANT LEVEL OF NEUROPROTECTION, IN PARTICULAR, IS EXERTED TOWARDS THE CHOLINERGIC NEURONS OF THE NBM PROJECTING TO THE CORTEX, AS DEMONSTRATED BY THE SUBSTANTIALLY HIGHER LEVELS OF CHOLINERGIC MARKERS MAINTAINED IN THE TARGET CORTICAL AREA OF VPA-TREATED RATS AFTER IBO INJECTION IN THE NBM. WE FURTHER SHOW THAT CHRONIC VPA ADMINISTRATION RESULTS IN INCREASED ACETYLATION OF HISTONE H3 IN BRAIN, CONSISTENT WITH THE HISTONE DEACETYLASE INHIBITORY ACTION OF VPA AND PUTATIVELY LINKED TO A NEUROPROTECTIVE ACTION OF THE DRUG MEDIATED AT THE EPIGENETIC LEVEL. 2009 4 2246 26 EPIGENETIC MODULATION OF INFLAMMATION AND SYNAPTIC PLASTICITY PROMOTES RESILIENCE AGAINST STRESS IN MICE. MAJOR DEPRESSIVE DISORDER IS ASSOCIATED WITH ABNORMALITIES IN THE BRAIN AND THE IMMUNE SYSTEM. CHRONIC STRESS IN ANIMALS SHOWED THAT EPIGENETIC AND INFLAMMATORY MECHANISMS PLAY IMPORTANT ROLES IN MEDIATING RESILIENCE AND SUSCEPTIBILITY TO DEPRESSION. HERE, THROUGH A HIGH-THROUGHPUT SCREENING, WE IDENTIFY TWO PHYTOCHEMICALS, DIHYDROCAFFEIC ACID (DHCA) AND MALVIDIN-3'-O-GLUCOSIDE (MAL-GLUC) THAT ARE EFFECTIVE IN PROMOTING RESILIENCE AGAINST STRESS BY MODULATING BRAIN SYNAPTIC PLASTICITY AND PERIPHERAL INFLAMMATION. DHCA/MAL-GLUC ALSO SIGNIFICANTLY REDUCES DEPRESSION-LIKE PHENOTYPES IN A MOUSE MODEL OF INCREASED SYSTEMIC INFLAMMATION INDUCED BY TRANSPLANTATION OF HEMATOPOIETIC PROGENITOR CELLS FROM STRESS-SUSCEPTIBLE MICE. DHCA REDUCES PRO-INFLAMMATORY INTERLEUKIN 6 (IL-6) GENERATIONS BY INHIBITING DNA METHYLATION AT THE CPG-RICH IL-6 SEQUENCES INTRONS 1 AND 3, WHILE MAL-GLUC MODULATES SYNAPTIC PLASTICITY BY INCREASING HISTONE ACETYLATION OF THE REGULATORY SEQUENCES OF THE RAC1 GENE. PERIPHERAL INFLAMMATION AND SYNAPTIC MALADAPTATION ARE IN LINE WITH NEWLY HYPOTHESIZED CLINICAL INTERVENTION TARGETS FOR DEPRESSION THAT ARE NOT ADDRESSED BY CURRENTLY AVAILABLE ANTIDEPRESSANTS. 2018 5 3093 26 GENOMIC AND EPIGENOMIC RESPONSES TO CHRONIC STRESS INVOLVE MIRNA-MEDIATED PROGRAMMING. STRESS REPRESENTS A CRITICAL INFLUENCE ON MOTOR SYSTEM FUNCTION AND HAS BEEN SHOWN TO IMPAIR MOVEMENT PERFORMANCE. WE HYPOTHESIZED THAT STRESS-INDUCED MOTOR IMPAIRMENTS ARE DUE TO BRAIN-SPECIFIC CHANGES IN MIRNA AND PROTEIN-ENCODING GENE EXPRESSION. HERE WE SHOW A CAUSAL LINK BETWEEN STRESS-INDUCED MOTOR IMPAIRMENT AND ASSOCIATED GENETIC AND EPIGENETIC RESPONSES IN RELEVANT CENTRAL MOTOR AREAS IN A RAT MODEL. EXPOSURE TO TWO WEEKS OF MILD RESTRAINT STRESS ALTERED THE EXPRESSION OF 39 GENES AND NINE MIRNAS IN THE CEREBELLUM. IN LINE WITH PERSISTENT BEHAVIOURAL IMPAIRMENTS, SOME CHANGES IN GENE AND MIRNA EXPRESSION WERE RESISTANT TO RECOVERY FROM STRESS. INTERESTINGLY, STRESS UP-REGULATED THE EXPRESSION OF ADIPOQ AND PROLACTIN RECEPTOR MRNAS IN THE CEREBELLUM. STRESS ALSO ALTERED THE EXPRESSION OF PRLR, MIR-186, AND MIR-709 IN HIPPOCAMPUS AND PREFRONTAL CORTEX. IN ADDITION, OUR FINDINGS DEMONSTRATE THAT MIR-186 TARGETS THE GENE EPS15. FURTHERMORE, WE FOUND AN AGE-DEPENDENT INCREASE IN EPHRINB3 AND GABAA4 RECEPTORS. THESE DATA SHOW THAT EVEN MILD STRESS RESULTS IN SUBSTANTIAL GENOMIC AND EPIGENOMIC CHANGES INVOLVING MIRNA EXPRESSION AND ASSOCIATED GENE TARGETS IN THE MOTOR SYSTEM. THESE FINDINGS SUGGEST A CENTRAL ROLE OF MIRNA-REGULATED GENE EXPRESSION IN THE STRESS RESPONSE AND IN ASSOCIATED NEUROLOGICAL FUNCTION. 2012 6 1182 33 CONVERGING AND DIFFERENTIAL BRAIN PHOSPHOLIPID DYSREGULATION IN THE PATHOGENESIS OF REPETITIVE MILD TRAUMATIC BRAIN INJURY AND ALZHEIMER'S DISEASE. REPETITIVE MILD TRAUMATIC BRAIN INJURY (RMTBI) IS A MAJOR EPIGENETIC RISK FACTOR FOR ALZHEIMER'S DISEASE (AD). THE PRECISE NATURE OF HOW RMTBI LEADS TO OR PRECIPITATES AD PATHOLOGY IS CURRENTLY UNKNOWN. NUMEROUS NEUROLOGICAL CONDITIONS HAVE SHOWN AN IMPORTANT ROLE FOR DYSFUNCTIONAL PHOSPHOLIPID METABOLISM AS A DRIVING FACTOR FOR THE PATHOGENESIS OF NEURODEGENERATIVE DISEASES. HOWEVER, THE PRECISE ROLE IN RMTBI AND AD REMAINS ELUSIVE. WE HYPOTHESIZED THAT A DETAILED PHOSPHOLIPID CHARACTERIZATION WOULD REVEAL PROFILES OF RESPONSE TO INJURY IN TBI THAT OVERLAP WITH AGE-DEPENDENT CHANGES IN AD AND THUS PROVIDE INSIGHTS INTO THE TBI-AD RELATIONSHIP. WE EMPLOYED A LIPIDOMIC APPROACH EXAMINING BRAIN PHOSPHOLIPID PROFILES FROM MOUSE MODELS OF RMTBI AND AD. CORTEX AND HIPPOCAMPAL TISSUE WERE COLLECTED AT 24 H, 3, 6, 9, AND 12 MONTHS POST-RMTBI, AND AT AGES REPRESENTING 'PRE', 'PERI' AND 'POST' ONSET OF AMYLOID PATHOLOGY (I.E., 3, 9, 15 MONTHS-OLD). TOTAL LEVELS OF PHOSPHATIDYLCHOLINE (PC), PHOSPHATIDYLETHANOLAMINE (PE), LYSOPE, AND PHOSPHATIDYLINOSITOL (PI), INCLUDING THEIR MONOUNSATURATED, POLYUNSATURATED AND SATURATED FATTY ACID (FA) CONTAINING SPECIES WERE SIGNIFICANTLY INCREASED AT ACUTE AND/OR CHRONIC TIME POINTS POST-INJURY IN BOTH BRAIN REGIONS. HOWEVER, LEVELS OF MOST PHOSPHOLIPID SPECIES IN PS1/APP MICE WERE NOMINAL IN THE HIPPOCAMPUS, WHILE IN THE CORTEX, LEVELS WERE SIGNIFICANTLY DECREASED AT AGES POST-ONSET OF AMYLOID PATHOLOGY. SPHINGOMYELIN AND LYSOPC LEVELS SHOWED COINCIDENTAL TRENDS IN OUR RMTBI AND AD MODELS WITHIN THE HIPPOCAMPUS, AN INCREASE AT ACUTE AND/OR CHRONIC TIME POINTS EXAMINED. THE RATIO OF ARACHIDONIC ACID (OMEGA-6 FA) TO DOCOSAHEXAENOIC ACID (OMEGA-3 FA)-CONTAINING PE SPECIES WAS INCREASED AT EARLY TIME POINTS IN THE HIPPOCAMPUS OF INJURED VERSUS SHAM MICE, AND IN PS1/APP MICE THERE WAS A COINCIDENTAL INCREASE COMPARED TO WILD TYPE LITTERMATES AT ALL TIME POINTS. THIS STUDY DEMONSTRATES SOME OVERLAPPING AND DIVERSE PHOSPHOLIPID PROFILES IN RMTBI AND AD MODELS. FUTURE STUDIES ARE REQUIRED TO CORROBORATE OUR FINDINGS IN HUMAN POST-MORTEM TISSUE. INVESTIGATION OF SECONDARY MECHANISMS TRIGGERED BY ABERRANT DOWNSTREAM ALTERATIONS IN BIOACTIVE METABOLITES OF THESE PHOSPHOLIPIDS, AND THEIR MODULATION AT THE APPROPRIATE TIME-WINDOWS OF OPPORTUNITY COULD HELP FACILITATE DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES TO AMELIORATE THE NEURODEGENERATIVE CONSEQUENCES OF RMTBI OR THE POTENTIAL TRIGGERING OF AD PATHOGENESIS BY RMTBI. 2019 7 237 32 ADENOSINE AUGMENTATION EVOKED BY AN ENT1 INHIBITOR IMPROVES MEMORY IMPAIRMENT AND NEURONAL PLASTICITY IN THE APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE. ALZHEIMER'S DISEASE (AD) IS A NEURODEGENERATIVE DISORDER CHARACTERIZED BY COGNITIVE IMPAIRMENT AND SYNAPTIC DYSFUNCTION. ADENOSINE IS AN IMPORTANT HOMEOSTATIC MODULATOR THAT CONTROLS THE BIOENERGETIC NETWORK IN THE BRAIN THROUGH REGULATING RECEPTOR-EVOKED SIGNALING PATHWAYS, BIOENERGETIC MACHINERIES, AND EPIGENETIC-MEDIATED GENE REGULATION. EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (ENT1) IS A MAJOR ADENOSINE TRANSPORTER THAT RECYCLES ADENOSINE FROM THE EXTRACELLULAR SPACE. IN THE PRESENT STUDY, WE REPORT THAT A SMALL ADENOSINE ANALOGUE (DESIGNATED J4) THAT INHIBITED ENT1 PREVENTED THE DECLINE IN SPATIAL MEMORY IN AN AD MOUSE MODEL (APP/PS1). ELECTROPHYSIOLOGICAL AND BIOCHEMICAL ANALYSES FURTHER DEMONSTRATED THAT CHRONIC TREATMENT WITH J4 NORMALIZED THE IMPAIRED BASAL SYNAPTIC TRANSMISSION AND LONG-TERM POTENTIATION (LTP) AT SCHAFFER COLLATERAL SYNAPSES AS WELL AS THE ABERRANT EXPRESSION OF SYNAPTIC PROTEINS (E.G., NR2A AND NR2B), ABNORMAL NEURONAL PLASTICITY-RELATED SIGNALING PATHWAYS (E.G., PKA AND GSK3BETA), AND DETRIMENTAL ELEVATION IN ASTROCYTIC A(2A)R EXPRESSION IN THE HIPPOCAMPUS AND CORTEX OF APP/PS1 MICE. IN CONCLUSION, OUR FINDINGS SUGGEST THAT MODULATION OF ADENOSINE HOMEOSTASIS BY J4 IS BENEFICIAL IN A MOUSE MODEL OF AD. OUR STUDY PROVIDES A POTENTIAL THERAPEUTIC STRATEGY TO DELAY THE PROGRESSION OF AD. 2018 8 5339 28 QUETIAPINE TREATMENT REVERSES DEPRESSIVE-LIKE BEHAVIOR AND REDUCES DNA METHYLTRANSFERASE ACTIVITY INDUCED BY MATERNAL DEPRIVATION. STRESS IN EARLY LIFE HAS BEEN APPOINTED AS AN IMPORTANT PHENOMENON IN THE ONSET OF DEPRESSION AND POOR RESPONSE TO TREATMENT WITH CLASSICAL ANTIDEPRESSANTS. FURTHERMORE, CHILDHOOD TRAUMA TRIGGERS EPIGENETIC CHANGES, WHICH ARE ASSOCIATED WITH THE PATHOPHYSIOLOGY OF MAJOR DEPRESSIVE DISORDER (MDD). TREATMENT WITH ATYPICAL ANTIPSYCHOTICS SUCH AS QUETIAPINE, EXERTS THERAPEUTIC EFFECT FOR MDD PATIENTS AND INDUCES EPIGENETIC CHANGES. THIS STUDY AIMED TO ANALYZE THE EFFECT OF CHRONIC TREATMENT WITH QUETIAPINE (20MG/KG) ON DEPRESSIVE-LIKE BEHAVIOR OF RATS SUBMITTED TO MATERNAL DEPRIVATION (MD), AS WELL AS THE ACTIVITY OF HISTONE ACETYLATION BY THE ENZYMES HISTONE ACETYL TRANSFERASES (HAT) AND DEACETYLASES (HDAC) AND DNA METHYLATION, THROUGH DNA METHYLTRANSFERASE ENZYME (DNMT) IN THE PREFRONTAL CORTEX (PFC), NUCLEUS ACCUMBENS (NAC) AND HIPPOCAMPUS. MATERNALLY DEPRIVED RATS HAD A DEPRESSIVE-LIKE BEHAVIOR IN THE FORCED SWIMMING TEST AND AN INCREASE IN THE HDAC AND DNMT ACTIVITIES IN THE HIPPOCAMPUS AND NAC. TREATMENT WITH QUETIAPINE REVERSED DEPRESSIVE-LIKE BEHAVIOR AND REDUCED THE DNMT ACTIVITY IN THE HIPPOCAMPUS. THIS IS THE FIRST STUDY TO SHOW THE ANTIDEPRESSANT-LIKE EFFECT OF QUETIAPINE IN ANIMALS SUBJECTED TO MD AND A PROTECTIVE EFFECT BY QUETIAPINE IN REDUCING EPIGENETIC CHANGES INDUCED BY STRESS IN EARLY LIFE. THESE RESULTS REINFORCE AN IMPORTANT ROLE OF QUETIAPINE AS THERAPY FOR MDD. 2017 9 195 19 ACF CHROMATIN-REMODELING COMPLEX MEDIATES STRESS-INDUCED DEPRESSIVE-LIKE BEHAVIOR. IMPROVED TREATMENT FOR MAJOR DEPRESSIVE DISORDER (MDD) REMAINS ELUSIVE BECAUSE OF THE LIMITED UNDERSTANDING OF ITS UNDERLYING BIOLOGICAL MECHANISMS. IT IS LIKELY THAT STRESS-INDUCED MALADAPTIVE TRANSCRIPTIONAL REGULATION IN LIMBIC NEURAL CIRCUITS CONTRIBUTES TO THE DEVELOPMENT OF MDD, POSSIBLY THROUGH EPIGENETIC FACTORS THAT REGULATE CHROMATIN STRUCTURE. WE ESTABLISH THAT PERSISTENT UPREGULATION OF THE ACF (ATP-UTILIZING CHROMATIN ASSEMBLY AND REMODELING FACTOR) ATP-DEPENDENT CHROMATIN-REMODELING COMPLEX, OCCURRING IN THE NUCLEUS ACCUMBENS OF STRESS-SUSCEPTIBLE MICE AND DEPRESSED HUMANS, IS NECESSARY FOR STRESS-INDUCED DEPRESSIVE-LIKE BEHAVIORS. WE FOUND THAT ALTERED ACF BINDING AFTER CHRONIC STRESS WAS CORRELATED WITH ALTERED NUCLEOSOME POSITIONING, PARTICULARLY AROUND THE TRANSCRIPTION START SITES OF AFFECTED GENES. THESE ALTERATIONS IN ACF BINDING AND NUCLEOSOME POSITIONING WERE ASSOCIATED WITH REPRESSED EXPRESSION OF GENES IMPLICATED IN SUSCEPTIBILITY TO STRESS. TOGETHER, OUR FINDINGS IDENTIFY THE ACF CHROMATIN-REMODELING COMPLEX AS A CRITICAL COMPONENT IN THE DEVELOPMENT OF SUSCEPTIBILITY TO DEPRESSION AND IN REGULATING STRESS-RELATED BEHAVIORS. 2015 10 3002 24 GENETIC, EPIGENETIC AND POSTTRANSCRIPTIONAL MECHANISMS FOR TREATMENT OF MAJOR DEPRESSION: THE 5-HT1A RECEPTOR GENE AS A PARADIGM. MAJOR DEPRESSION AND ANXIETY ARE HIGHLY PREVALENT AND INVOLVE CHRONIC DYSREGULATION OF SEROTONIN, BUT THEY REMAIN POORLY UNDERSTOOD. HERE, WE REVIEW NOVEL TRANSCRIPTIONAL (GENETIC, EPIGENETIC) AND POSTTRANSCRIPTIONAL (MICRORNA, ALTERNATIVE SPLICING) MECHANISMS IMPLICATED IN MENTAL ILLNESS, FOCUSING ON A KEY SEROTONIN-RELATED REGULATOR, THE SEROTONIN 1A (5-HT1A) RECEPTOR. FUNCTIONAL SINGLE-NUCLEOTIDE POLYMORPHISMS AND STRESS-INDUCED DNA METHYLATION OF THE 5-HT1A PROMOTER CONVERGE TO DIFFERENTIALLY ALTER PRE- AND POSTSYNAPTIC 5-HT1A RECEPTOR EXPRESSION ASSOCIATED WITH MAJOR DEPRESSION AND REDUCED THERAPEUTIC RESPONSE TO SEROTONERGIC ANTIDEPRESSANTS. MAJOR DEPRESSION IS ALSO ASSOCIATED WITH ALTERED LEVELS OF SPLICE FACTORS AND MICRORNA, POSTTRANSCRIPTIONAL MECHANISMS THAT REGULATE RNA STABILITY. THE HUMAN 5-HT1A 3'-UNTRANSLATED REGION IS ALTERNATIVELY SPLICED, REMOVING MICRORNA SITES AND INCREASING 5-HT1A EXPRESSION, WHICH IS REDUCED IN MAJOR DEPRESSION AND MAY BE GENOTYPE-DEPENDENT. THUS, THE 5-HT1A RECEPTOR GENE ILLUSTRATES THE CONVERGENCE OF GENETIC, EPIGENETIC AND POSTTRANSCRIPTIONAL MECHANISMS IN GENE EXPRESSION, NEURODEVELOPMENT AND NEUROPLASTICITY, AND MAJOR DEPRESSION. UNDERSTANDING GENE REGULATORY MECHANISMS COULD ENHANCE THE DETECTION, CATEGORIZATION AND PERSONALIZED TREATMENT OF MAJOR DEPRESSION. 2019 11 5832 21 STRESS-INDUCED EPIGENETIC CHANGES IN HIPPOCAMPAL MKP-1 PROMOTE PERSISTENT DEPRESSIVE BEHAVIORS. CHRONIC STRESS INDUCES PERSISTENT DEPRESSIVE BEHAVIORS. STRESS-INDUCED TRANSCRIPTIONAL ALTERATION OVER THE HOMEOSTATIC RANGE IN STRESS HORMONE-SENSITIVE BRAIN REGIONS IS BELIEVED TO UNDERLIE LONG-LASTING DEPRESSIVE BEHAVIORS. HOWEVER, THE DETAILED MECHANISMS BY WHICH CHRONIC STRESS CAUSES THOSE ADAPTIVE CHANGES ARE NOT CLEARLY UNDERSTOOD. IN THE PRESENT STUDY, WE INVESTIGATED WHETHER EPIGENETIC CHANGES REGULATE STRESS-INDUCED DEPRESSIVE BEHAVIORS. WE FOUND THAT CHRONIC STRESS IN MICE DOWNREGULATES THE EPIGENETIC FACTORS HDAC2 AND SUV39H1 IN THE HIPPOCAMPUS. A SERIES OF FOLLOW-UP ANALYSES INCLUDING CHIP ASSAY AND SIRNA-MEDIATED FUNCTIONAL ANALYSES REVEAL THAT GLUCOCORTICOIDS RELEASED BY STRESS CUMULATIVELY INCREASE MKP-1 EXPRESSION IN THE HIPPOCAMPUS, AND INCREASED MKP-1 THEN DEBILITATES P-CREB AND PPARGAMMA, WHICH IN TURN SUPPRESS THE EPIGENETIC FACTORS HDAC2 AND SUV39H1. FURTHERMORE, HDAC2 AND SUV39H1 NORMALLY SUPPRESS THE TRANSCRIPTION OF THE MKP-1, AND THEREFORE THE REDUCED EXPRESSION OF HDAC2 AND SUV39H1 INCREASES MKP-1 EXPRESSION. ACCORDINGLY, REPEATED STRESS PROGRESSIVELY STRENGTHENS A VICIOUS CYCLE OF THE MKP-1 SIGNALING CASCADE THAT FACILITATES DEPRESSIVE BEHAVIORS. THESE RESULTS SUGGEST THAT THE HIPPOCAMPAL STRESS ADAPTATION SYSTEM COMPRISING HDAC2/SUV39H1-REGULATED MKP-1 SIGNALING NETWORK DETERMINES THE VULNERABILITY TO CHRONIC STRESS AND THE MAINTENANCE OF DEPRESSIVE BEHAVIORS. 2019 12 5474 26 RESTORATION OF HISTONE ACETYLATION AMELIORATES DISEASE AND METABOLIC ABNORMALITIES IN A FUS MOUSE MODEL. DYSREGULATION OF EPIGENETIC MECHANISMS IS EMERGING AS A CENTRAL EVENT IN NEURODEGENERATIVE DISORDERS, INCLUDING AMYOTROPHIC LATERAL SCLEROSIS (ALS). IN MANY MODELS OF NEURODEGENERATION, GLOBAL HISTONE ACETYLATION IS DECREASED IN THE AFFECTED NEURONAL TISSUES. HISTONE ACETYLATION IS CONTROLLED BY THE ANTAGONISTIC ACTIONS OF TWO PROTEIN FAMILIES -THE HISTONE ACETYLTRANSFERASES (HATS) AND THE HISTONE DEACETYLASES (HDACS). DRUGS INHIBITING HDAC ACTIVITY ARE ALREADY USED IN THE CLINIC AS ANTI-CANCER AGENTS. THE AIM OF THIS STUDY WAS TO EXPLORE THE THERAPEUTIC POTENTIAL OF HDAC INHIBITION IN THE CONTEXT OF ALS. WE DISCOVERED THAT TRANSGENIC MICE OVEREXPRESSING WILD-TYPE FUS ("TG FUS+/+"), WHICH RECAPITULATE MANY ASPECTS OF HUMAN ALS, SHOWED REDUCED GLOBAL HISTONE ACETYLATION AND ALTERATIONS IN METABOLIC GENE EXPRESSION, RESULTING IN A DYSREGULATED METABOLIC HOMEOSTASIS. CHRONIC TREATMENT OF TG FUS+/+ MICE WITH ACY-738, A POTENT HDAC INHIBITOR THAT CAN CROSS THE BLOOD-BRAIN BARRIER, AMELIORATED THE MOTOR PHENOTYPE AND SUBSTANTIALLY EXTENDED THE LIFE SPAN OF THE TG FUS+/+ MICE. AT THE MOLECULAR LEVEL, ACY-738 RESTORED GLOBAL HISTONE ACETYLATION AND METABOLIC GENE EXPRESSION, THEREBY RE-ESTABLISHING METABOLITE LEVELS IN THE SPINAL CORD. TAKEN TOGETHER, OUR FINDINGS LINK EPIGENETIC ALTERATIONS TO METABOLIC DYSREGULATION IN ALS PATHOLOGY, AND HIGHLIGHT ACY-738 AS A POTENTIAL THERAPEUTIC STRATEGY TO TREAT THIS DEVASTATING DISEASE. 2019 13 905 26 CHRONIC EXPOSURE TO CANNABINOIDS DURING ADOLESCENCE CAUSES LONG-LASTING BEHAVIORAL DEFICITS IN ADULT MICE. REGULAR USE OF MARIJUANA DURING ADOLESCENCE ENHANCES THE RISK OF LONG-LASTING NEUROBIOLOGICAL CHANGES IN ADULTHOOD. THE PRESENT STUDY WAS AIMED AT ASSESSING THE EFFECT OF LONG-TERM ADMINISTRATION OF THE SYNTHETIC CANNABINOID WIN55212.2 DURING ADOLESCENCE IN YOUNG ADULT MICE. ADOLESCENT MICE AGED 5 WEEKS WERE SUBJECTED DAILY TO THE PHARMACOLOGICAL ACTION OF WIN55212.2 FOR 3 WEEKS AND WERE THEN LEFT UNDISTURBED IN THEIR HOME CAGE FOR A 5-WEEK PERIOD AND FINALLY EVALUATED BY BEHAVIORAL TESTING. MICE THAT RECEIVED THE DRUG DURING ADOLESCENCE SHOWED MEMORY IMPAIRMENT IN THE MORRIS WATER MAZE, AS WELL AS A DOSE-DEPENDENT MEMORY IMPAIRMENT IN FEAR CONDITIONING. IN ADDITION, THE ADMINISTRATION OF 3 MG/KG WIN55212.2 IN ADOLESCENCE INCREASED ADULT HIPPOCAMPAL AEA LEVELS AND PROMOTED DNA HYPERMETHYLATION AT THE INTRAGENIC REGION OF THE INTRACELLULAR SIGNALING MODULATOR RGS7, WHICH WAS ACCOMPANIED BY A LOWER RATE OF MRNA TRANSCRIPTION OF THIS GENE, SUGGESTING A POTENTIAL CAUSAL RELATION. ALTHOUGH THE CONCRETE MECHANISMS UNDERLYING THE BEHAVIORAL OBSERVATIONS REMAIN TO BE ELUCIDATED, WE DEMONSTRATE THAT LONG-TERM ADMINISTRATION OF 3 MG/KG OF WIN DURING ADOLESCENCE LEADS TO INCREASED ENDOCANNABINOID LEVELS AND ALTERED RGS7 EXPRESSION IN ADULTHOOD AND ESTABLISH A POTENTIAL LINK TO EPIGENETIC CHANGES. 2017 14 20 31 5-HYDROXYMETHYLATION-ASSOCIATED EPIGENETIC MODIFIERS OF ALZHEIMER'S DISEASE MODULATE TAU-INDUCED NEUROTOXICITY. ALZHEIMER'S DISEASE (AD) IS A CHRONIC NEURODEGENERATIVE DISORDER CHARACTERIZED BY PROGRESSIVE DETERIORATION OF COGNITIVE FUNCTION. PATHOGENESIS OF AD IS INCOMPLETELY UNDERSTOOD; EVIDENCE SUGGESTS A ROLE FOR EPIGENETIC REGULATION, IN PARTICULAR THE CYTOSINE MODIFICATIONS 5-METHYLCYTOSINE AND 5-HYDROXYMETHYLCYTOSINE (5HMC). 5HMC IS ENRICHED IN THE NERVOUS SYSTEM AND DISPLAYS NEURODEVELOPMENT AND AGE-RELATED CHANGES. TO DETERMINE THE ROLE OF 5HMC IN AD, WE PERFORMED GENOME-WIDE ANALYSES OF 5HMC IN DNA FROM PREFRONTAL CORTEX OF POST-MORTEM AD PATIENTS, AND RNA-SEQ TO CORRELATE CHANGES IN 5HMC WITH TRANSCRIPTIONAL CHANGES. WE IDENTIFIED 325 GENES CONTAINING DIFFERENTIALLY HYDROXYMETHYLATED LOCI (DHMLS) IN BOTH DISCOVERY AND REPLICATION DATASETS. THESE ARE ENRICHED FOR PATHWAYS INVOLVED IN NEURON PROJECTION DEVELOPMENT AND NEUROGENESIS. OF THESE, 140 SHOWED CHANGES IN GENE EXPRESSION. PROTEINS ENCODED BY THESE GENES FORM DIRECT PROTEIN-PROTEIN INTERACTIONS WITH AD-ASSOCIATED GENES, EXPANDING THE NETWORK OF GENES IMPLICATED IN AD. WE IDENTIFIED AD-ASSOCIATED SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) LOCATED WITHIN OR NEAR DHMLS, SUGGESTING THESE SNPS MAY IDENTIFY REGIONS OF EPIGENETIC GENE REGULATION THAT PLAY A ROLE IN AD PATHOGENESIS. FINALLY, USING AN EXISTING AD FLY MODEL, WE SHOWED SOME OF THESE GENES MODULATE AD-ASSOCIATED TOXICITY. OUR DATA IMPLICATE NEURONAL PROJECTION DEVELOPMENT AND NEUROGENESIS PATHWAYS AS POTENTIAL TARGETS IN AD. BY INCORPORATING EPIGENOMIC AND TRANSCRIPTOMIC DATA WITH GENOME-WIDE ASSOCIATION STUDIES DATA, WITH VERIFICATION IN THE DROSOPHILA MODEL, WE CAN EXPAND THE KNOWN NETWORK OF GENES INVOLVED IN DISEASE PATHOGENESIS AND IDENTIFY EPIGENETIC MODIFIERS OF ALZHEIMER'S DISEASE. 2016 15 3370 36 HISTONE MODIFICATION OF NEDD4 UBIQUITIN LIGASE CONTROLS THE LOSS OF AMPA RECEPTORS AND COGNITIVE IMPAIRMENT INDUCED BY REPEATED STRESS. STRESS AND THE MAJOR STRESS HORMONE CORTICOSTERONE INDUCE PROFOUND INFLUENCES IN THE BRAIN. ALTERED HISTONE MODIFICATION AND TRANSCRIPTIONAL DYSFUNCTION HAVE BEEN IMPLICATED IN STRESS-RELATED MENTAL DISORDERS. WE PREVIOUSLY FOUND THAT REPEATED STRESS CAUSED AN IMPAIRMENT OF PREFRONTAL CORTEX (PFC)-MEDIATED COGNITIVE FUNCTIONS BY INCREASING THE UBIQUITINATION AND DEGRADATION OF AMPA-TYPE GLUTAMATE RECEPTORS VIA A MECHANISM DEPENDING ON THE E3 UBIQUITIN LIGASE NEDD4. HERE, WE DEMONSTRATED THAT IN PFC OF REPEATEDLY STRESSED RATS, ACTIVE GLUCOCORTICOID RECEPTOR HAD THE INCREASED BINDING TO THE GLUCOCORTICOID RESPONSE ELEMENT OF HISTONE DEACETYLASE 2 (HDAC2) PROMOTER, RESULTING IN THE UPREGULATION OF HDAC2. INHIBITION OR KNOCK-DOWN OF HDAC2 BLOCKED THE STRESS-INDUCED IMPAIRMENT OF SYNAPTIC TRANSMISSION, AMPAR EXPRESSION, AND RECOGNITION MEMORY. FURTHERMORE, WE FOUND THAT, IN STRESSED ANIMALS, THE HDAC2-DEPENDENT DOWNREGULATION OF HISTONE METHYLTRANSFERASE EHMT2 (G9A) LED TO THE LOSS OF REPRESSIVE HISTONE METHYLATION AT THE NEDD4-1 PROMOTER AND THE TRANSCRIPTIONAL ACTIVATION OF NEDD4. THESE RESULTS HAVE PROVIDED AN EPIGENETIC MECHANISM AND A POTENTIAL TREATMENT STRATEGY FOR THE DETRIMENTAL EFFECTS OF CHRONIC STRESS. SIGNIFICANCE STATEMENT: PROLONGED STRESS EXPOSURE CAN INDUCE ALTERED HISTONE MODIFICATION AND TRANSCRIPTIONAL DYSFUNCTION, WHICH MAY UNDERLIE THE PROFOUND INFLUENCE OF STRESS IN REGULATING BRAIN FUNCTIONS. WE REPORT AN IMPORTANT FINDING ABOUT THE EPIGENETIC MECHANISM CONTROLLING THE DETRIMENTAL EFFECTS OF REPEATED STRESS ON SYNAPTIC TRANSMISSION AND COGNITIVE FUNCTION. FIRST, IT HAS REVEALED THE STRESS-INDUCED ALTERATION OF KEY EPIGENETIC REGULATORS HDAC2 AND EHMT2, WHICH DETERMINES THE SYNAPTIC AND BEHAVIORAL EFFECTS OF REPEATED STRESS. SECOND, IT HAS UNCOVERED THE STRESS-INDUCED HISTONE MODIFICATION OF THE TARGET GENE NEDD4, AN E3 LIGASE THAT IS CRITICALLY INVOLVED IN THE UBIQUITINATION AND DEGRADATION OF AMPA RECEPTORS AND COGNITION. THIRD, IT HAS PROVIDED THE EPIGENETIC APPROACH, HDAC2 INHIBITION OR KNOCK-DOWN, TO RESCUE SYNAPTIC AND COGNITIVE FUNCTIONS IN STRESSED ANIMALS. 2016 16 1907 38 ENRICHED ENVIRONMENT PRIORS TO TET1 HIPPOCAMPAL ADMINISTRATION FOR REGULATING PSYCHIATRIC BEHAVIORS VIA GLIAL REACTIVITY IN CHRONIC CEREBRAL HYPOPERFUSION MODELS. BACKGROUND: CHRONIC CEREBRAL HYPOPERFUSION (CCH) HAS BEEN GRADUALLY REGARDED AS A COMMON ETIOLOGIC MECHANISM FOR COGNITIVE AND PSYCHIATRIC DISTURBANCES. TEN-ELEVEN TRANSLOCATION METHYLCYTOSINE DIOXYGENASE 1 (TET1) PLAYED AN IMPORTANT ROLE IN ADULT HIPPOCAMPAL NEUROGENESIS (AHN), NEURONAL CIRCUITS FORMATION, COGNITION AND PSYCHIATRIC DISORDERS. ENRICHED ENVIRONMENT (EE) SHOWED A BENEFICIAL EFFECT ON COGNITION AND DEPRESSION VIA EFFECTIVELY REGULATING AHN AND GLIAL REACTIVITY. THIS STUDY AIMED TO ASSESS WHICH STRATEGY WAS FEASIBLE TO IMPROVE COGNITION AND PSYCHIATRIC DISTURBANCES BY COMPARING THE TET1 HIPPOCAMPAL MICROINJECTION AND EE IN CCH MODELS AND TO INVESTIGATE THE POSSIBLE MECHANISMS. METHOD: CCH RATS WERE ESTABLISHED VIA PERMANENT BILATERAL COMMON CAROTID ARTERY OCCLUSION (2-VO). RATS WERE STEREOTAXICALLY INJECTED WITH THE HUMAN CATALYTIC DOMAIN OF TET1 (HTET1) TO OVEREXPRESS THE HTET1 IN THE HIPPOCAMPUS 10 DAYS BEFORE 2-VO. 3 DAYS AFTER 2-VO, RATS WERE SUBJECTED TO STANDARD ENVIRONMENT OR EE WITH FREE ACCESS TO FOOD AND WATER. BEHAVIORAL TESTS WERE USED TO APPRAISE DEPRESSION AND COGNITION BEFORE SACRIFICE. EPIGENETIC MOLECULES, ADULT NEUROGENESIS, SYNAPTIC PROTEINS EXPRESSION, AND GLIAL ACTIVATION WERE ANALYZED USING IMMUNOFLUORESCENT STAINING, QRT-PCR AND WESTERN BLOT. RESULTS: IN THE PRESENT STUDY, WE FOUND BOTH EE AND GENETICAL TREATMENT WITH OVEREXPRESSING HTET1 WERE SUFFICIENT FOR STIMULATING AHN. HOWEVER, PROMOTING ANH COULD NOT DEAL WITH THE COGNITIVE DYSFUNCTION AND DEPRESSIVE-LIKE BEHAVIORS IN CCH RATS. NOTABLY, A HEALTHY LOCAL BRAIN ENVIRONMENT WITH ELEVATED BDNF AND ASTROCYTES WAS CONDUCIVE TO IMPROVING COGNITIVE DYSFUNCTION. MEANWHILE, ASTROCYTES WERE INVOLVED IN THE COGNITIVE REGULATING PROCESS OF NEURONS, PRESYNAPTIC FUNCTION AND MICROGLIA. IN GENERAL, WE HELD THAT DEPRESSIVE DISTURBANCES WERE DETERMINED BY BDNF LEVELS, NEURONAL AND PRESYNAPTIC FUNCTION, AS WELL AS GLIAL ACTIVATION CONTAINING ASTROCYTES AND MICROGLIA. TO FURTHER SUPPORT THIS POINT, WE INVESTIGATED SEVERE DEPRESSIVE SYMPTOMS THAT WERE STRONGLY CORRELATED WITH THE ACTIVATION OF ASTROGLIA AND MICROGLIA. IMPORTANTLY, CAUSAL MEDIATION ANALYSIS SHOWED SIGNIFICANT MEDIATION BY THE PRESENCE OF REACTIVE GLIAL CELLS IN THE RELATION BETWEEN NEURAL PLASTICITY AND DEPRESSIVE SYMPTOMS. FINALLY, WE SHOWED EE PERFORMED BETTER THAN HTET1 TREATMENT FOR COGNITIVE DEFICITS AND DEPRESSION. EE WITH LESS GLIAL REACTIVITY WAS MUCH MORE RESISTANT TO DEPRESSION, WHILE HTET1 WITH MORE GLIAL ACTIVATION WAS MORE VULNERABLE TO DEPRESSIVE DISORDERS. CONCLUSIONS: EE WAS LIKELY TO BE SUPERIOR TO TET1 HIPPOCAMPAL ADMINISTRATION FOR COGNITION AND PSYCHIATRIC BEHAVIORS IN CCH RATS. FURTHERMORE, A HEALTHY LOCAL BRAIN ENVIRONMENT WITH ELEVATED BDNF AND ASTROCYTES WAS CONDUCIVE TO IMPROVING COGNITIVE DYSFUNCTION. MORE GLIAL ACTIVATION, AND MORE VULNERABLE TO DEPRESSIVE DISORDERS. THESE RESULTS WERE IMPORTANT FOR OUR UNDERSTANDING OF DISEASE MECHANISMS AND PROVIDED VALUABLE TOOLS FOR THE OVERALL MANAGEMENT OF CCH PATIENTS. 2022 17 3833 31 INVOLVEMENT OF THE DYNORPHIN/KOR SYSTEM ON THE NOCICEPTIVE, EMOTIONAL AND COGNITIVE MANIFESTATIONS OF JOINT PAIN IN MICE. JOINT PAIN IS A MAJOR CLINICAL PROBLEM MAINLY ASSOCIATED TO OSTEOARTHRITIS, AND CHARACTERIZED BY ARTICULAR CARTILAGE DEGRADATION RESULTING IN A COMPLEX CHRONIC PAIN STATE THAT INCLUDES NOCICEPTIVE, EMOTIONAL AND COGNITIVE MANIFESTATIONS. MEMORY IMPAIRMENT, DEPRESSIVE- AND ANXIETY-LIKE SYMPTOMS HAVE BEEN REPORTED TO BE ASSOCIATED WITH CHRONIC PAIN, LEADING TO A DECREASE OF LIFE QUALITY. IN THIS STUDY, WE EVALUATED THE INVOLVEMENT OF THE ENDOGENOUS DYNORPHIN/KAPPA OPIOID RECEPTOR (KOR) SYSTEM ON THE NOCICEPTIVE, EMOTIONAL, COGNITIVE, NEUROCHEMICAL AND EPIGENETIC MANIFESTATIONS OF JOINT PAIN. THE MURINE MODEL OF MONOSODIUM IODOACETATE (MIA) WAS USED TO INDUCE JOINT PAIN IN KNOCKOUT MICE FOR KOR (KOR-KO), PRODYNORPHIN (PDYN-KO) AND THEIR WILD-TYPE (WT) LITTERMATES. KOR-KO AND PDYN-KO MICE DEVELOPED MECHANICAL ALLODYNIA AFTER INTRA-ARTICULAR INJECTION OF MIA. THIS ALLODYNIA WAS SIGNIFICANTLY INCREASED IN BOTH KOR-KO AND PDYN-KO WHEN COMPARED TO WT MICE. ACCORDINGLY, BOTH MUTANTS SHOWED INCREASED MICROGLIAL ACTIVATION ON THE LUMBAR SECTION OF THE SPINAL CORD AFTER MIA. THE EMOTIONAL RESPONSES WERE EVALUATED BY MEASURING ANXIETY-LIKE BEHAVIOUR IN THE ELEVATED PLUS MAZE AND ANHEDONIA AS DEPRESSIVE-LIKE BEHAVIOUR, AND COGNITIVE ALTERATIONS IN THE OBJECT RECOGNITION PARADIGM. EMOTIONAL AND COGNITIVE IMPAIRMENTS AFTER JOINT PAIN WERE DIFFERENTLY MODIFIED IN KOR-KO AND PDYN-KO MICE. ALTERATIONS OF CORTICOTROPIN-RELEASING FACTOR (CRF) ON THE AMYGDALA AND HIPPOCAMPUS AND DOWN REGULATION OF HISTONE 3 ACETYLATION ON THE AMYGDALA SUGGEST A POSSIBLE MECHANISM TO EXPLAIN THESE EMOTIONAL AND COGNITIVE MANIFESTATIONS. OUR RESULTS REVEAL A SPECIFIC INVOLVEMENT OF THE DYNORPHIN/KOR SYSTEM ON JOINT PAIN MANIFESTATIONS THAT ARE USUALLY ASSOCIATED TO OSTEOARTHRITIS. 2017 18 280 29 AGE-RELATED MIRNAS DYSREGULATION AND ABNORMAL BACE1 EXPRESSION FOLLOWING PB EXPOSURE IN ADOLESCENT MICE. NUMBERS OF EMERGING EVIDENCE SUGGEST THAT LEAD (PB) EXPOSURE CONTRIBUTES TO COGNITIVE DECLINE AND MIGHT ALSO INCREASE THE RISK OF ALZHEIMER'S DISEASE (AD) DEMENTIA IN THE ELDERLY BY INCREASING THE BETA-AMYLOID BURDEN. HERE, WE AIMED TO CHARACTERIZE THE EFFECTS OF PB ON THE POST-TRANSCRIPTIONAL REGULATORS, MICRORNAS (MIRNAS), WHICH MAY PARTICIPATE IN AD PATHOGENESIS. AT FIRST, EARLY CHRONIC PB EXPOSURE ON NEURONAL MIRNAS EXPRESSION WITH INCREASING AGING WAS PROFILED TO ELUCIDATE THE ASSOCIATION OF THREE SELECTED MIRNAS WITH BETA-SITE APP-CLEAVING ENZYME 1(BACE1), A RATE-LIMITING ENZYME FOR BETA-AMYLOID (ABETA) PRODUCTION. NEXT, WE VERIFIED CHANGES IN BACE1 WERE OBSERVED BY REGULATING MIRNAS EXPRESSION IN VITRO. WHILE PB PROMOTED BACE1 LEVELS, BACE1 LEVELS WERE REDUCED IN SH-SY5Y CELLS WITH MIR-124-3P MIMIC, SUGGESTING FOR THE FIRST TIME THAT MIR-124-3P/BACE1 PATHWAY MODULATION IS CRITICALLY INVOLVED IN PB-INDUCED AD-LIKE AMYLOIDOGENIC PROCESSING. FINDINGS FROM THIS STUDY COULD PROVIDE NEW INSIGHT INTO THE MOLECULAR MECHANISMS OF PB-ASSOCIATED NEURODEGENERATIVE PATHOGENESIS FROM AN EPIGENETIC PERSPECTIVE. 2022 19 2051 23 EPIGENETIC CONDITIONING INDUCES INTERGENERATIONAL RESILIENCE TO DEMENTIA IN A MOUSE MODEL OF VASCULAR COGNITIVE IMPAIRMENT. INTRODUCTION: EPIGENETIC STIMULI INDUCE BENEFICIAL OR DETRIMENTAL CHANGES IN GENE EXPRESSION, AND CONSEQUENTLY, PHENOTYPE. SOME OF THESE PHENOTYPES CAN MANIFEST ACROSS THE LIFESPAN-AND EVEN IN SUBSEQUENT GENERATIONS. HERE, WE USED A MOUSE MODEL OF VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA (VCID) TO DETERMINE WHETHER EPIGENETICALLY INDUCED RESILIENCE TO SPECIFIC DEMENTIA-RELATED PHENOTYPES IS HERITABLE BY FIRST-GENERATION PROGENY. METHODS: OUR SYSTEMIC EPIGENETIC THERAPY CONSISTED OF 2 MONTHS OF REPETITIVE HYPOXIC "CONDITIONING" (RHC) PRIOR TO CHRONIC CEREBRAL HYPOPERFUSION IN ADULT C57BL/6J MICE. RESULTANT CHANGES IN OBJECT RECOGNITION MEMORY AND HIPPOCAMPAL LONG-TERM POTENTIATION (LTP) WERE ASSESSED 3 AND 4 MONTHS LATER, RESPECTIVELY. RESULTS: HYPOPERFUSION-INDUCED MEMORY/PLASTICITY DEFICITS WERE ABROGATED BY RHC. MOREOVER, SIMILARLY ROBUST DEMENTIA RESILIENCE WAS DOCUMENTED IN UNTREATED CEREBRAL HYPOPERFUSED ANIMALS DERIVED FROM RHC-TREATED PARENTS. CONCLUSIONS: OUR RESULTS IN EXPERIMENTAL VCID UNDERSCORE THE EFFICACY OF EPIGENETICS-BASED TREATMENTS TO PREVENT MEMORY LOSS, AND DEMONSTRATE FOR THE FIRST TIME THE HERITABILITY OF AN INDUCED RESILIENCE TO DEMENTIA. 2022 20 1162 24 CONTRASTING EFFECTS OF ACUTE AND CHRONIC STRESS ON THE TRANSCRIPTOME, EPIGENOME, AND IMMUNE RESPONSE OF ATLANTIC SALMON. STRESS EXPERIENCED DURING EARLY LIFE MAY HAVE LASTING EFFECTS ON THE IMMUNE SYSTEM, WITH IMPACTS ON HEALTH AND DISEASE DEPENDENT ON THE NATURE AND DURATION OF THE STRESSOR. THE EPIGENOME IS ESPECIALLY SENSITIVE TO ENVIRONMENTAL STIMULI DURING EARLY LIFE AND REPRESENTS A POTENTIAL MECHANISM THROUGH WHICH STRESS MAY CAUSE LONG-LASTING HEALTH EFFECTS. HOWEVER, THE EXTENT TO WHICH THE EPIGENOME RESPONDS DIFFERENTLY TO CHRONIC VS ACUTE STRESSORS IS UNCLEAR, ESPECIALLY FOR NON-MAMMALIAN SPECIES. WE EXAMINED THE EFFECTS OF ACUTE STRESS (COLD-SHOCK DURING EMBRYOGENESIS) AND CHRONIC STRESS (ABSENCE OF TANK ENRICHMENT DURING LARVAL-STAGE) ON GLOBAL GENE EXPRESSION (USING RNA-SEQ) AND DNA METHYLATION (USING RRBS) IN THE GILLS OF ATLANTIC SALMON (SALMO SALAR) FOUR MONTHS AFTER HATCHING. CHRONIC STRESS INDUCED PRONOUNCED TRANSCRIPTIONAL DIFFERENCES, WHILE ACUTE STRESS CAUSED FEW LASTING TRANSCRIPTIONAL EFFECTS. HOWEVER, BOTH ACUTE AND CHRONIC STRESS CAUSED LASTING AND CONTRASTING CHANGES IN THE METHYLOME. CRUCIALLY, WE FOUND THAT ACUTE STRESS ENHANCED TRANSCRIPTIONAL IMMUNE RESPONSE TO A PATHOGENIC CHALLENGE (BACTERIAL LIPOPOLYSACCHARIDE, LPS), WHILE CHRONIC STRESS SUPPRESSED IT. WE IDENTIFIED STRESS-INDUCED CHANGES IN PROMOTER AND GENE-BODY METHYLATION THAT WERE ASSOCIATED WITH ALTERED EXPRESSION FOR A SMALL PROPORTION OF IMMUNE-RELATED GENES, AND EVIDENCE OF WIDER EPIGENETIC REGULATION WITHIN SIGNALLING PATHWAYS INVOLVED IN IMMUNE RESPONSE. OUR RESULTS SUGGEST THAT STRESS CAN AFFECT IMMUNO-COMPETENCE THROUGH EPIGENETIC MECHANISMS, AND HIGHLIGHT THE MARKEDLY DIFFERENT EFFECTS OF CHRONIC LARVAL AND ACUTE EMBRYONIC STRESS. THIS KNOWLEDGE COULD BE USED TO HARNESS THE STIMULATORY EFFECTS OF ACUTE STRESS ON IMMUNITY, PAVING THE WAY FOR IMPROVED STRESS AND DISEASE MANAGEMENT THROUGH EPIGENETIC CONDITIONING. 2018